Addressing the Unique Challenges of Opioid Use Disorder in Women
Deaths from drug overdoses are the number one cause of injury death in the U.S. Most of these deaths are related to the misuse of prescription opioids and heroin. While men were more likely than women to die of opioid overdose, the number of overdose deaths from opioids among women has increased substantially. Since 1999, women’s deaths have quadrupled from prescription opioid overdose.
Consider the following:
- Nearly 48,000 women died of prescription opioid overdose between 1999 and 2010.
- For every woman who dies of a prescription opioid overdose, over 30 of them go the emergency department for opioid misuse or abuse.
Women’s biological differences may influence susceptibility to substance abuse, which could have implications for prevention and treatment. In order to identify and treat women most at risk, health care providers must be able to recognize and consider these differences.
Join us as we discuss how health care providers, researchers, and the public health community can best address the complexities of opioid use disorder among women. Speakers will give an overview of the federal response to the disorder, along with approaches to care and prevention of substance use.
Future Grand Rounds topics include promoting medication adherence for chronic disease prevention and control and emerging tick-borne pathogens.
Beyond the Data – Addressing the Unique Challenges of Opioid Use Disorder in Women
Dr. John Iskander and Dr. Mishka Terplan, discuss how the opioid epidemic is impacting women differently than men. Tune in to hear how women’s gender and biological differences need to be considered when providing care and recommending policy on federal, state, and local levels.
Karin A. Mack, PhD
Associate Director for Science, Division of Analysis Research and Practice Integration, National Center for Injury Prevention and Control, CDC
“Overview of Opioid Use Disorder in Women and the Federal Response”
Linda Frazier, RN, MCHES, CADC
Director, Addictions Initiatives, Chair, APHA ATOD Section, Advocates for Human Potential, Inc.
“Comprehensive Approaches to Care of Women with Substance Use Disorders”
Mishka Terplan, MD, MPH, FACOG, FASAM
Professor, Department of Obstetrics and Gynecology, Professor, Department of Psychiatry, Associate Director, Addiction Medicine, Virginia Commonwealth University
“Prevention of Substance Use through Integration into Healthcare”
John Iskander, MD, MPH, Scientific Director, Public Health Grand Rounds
Phoebe Thorpe, MD, MPH, Deputy Scientific Director, Public Health Grand Rounds
Susan Laird, MSN, RN, Communications Director, Public Health Grand Rounds
- Page last reviewed: December 30, 2016
- Page last updated: December 30, 2016
- Content source:
- Centers for Disease Control and Prevention
- Page maintained by: Office of Associate Director of Communication, Division of Public Affairs